IBM, Novo Nordisk Team on Watson-Based Diabetes Care Solution
IBM has teamed up with diabetes care leader Novo Nordisk to create new solutions based on IBM's Watson cognitive computing technology.Novo Nordisk and IBM’s Watson Health unit announced that the two organizations will work together to create diabetes care solutions built on the Watson Health Cloud. The agreement combines Novo Nordisk’s deep understanding of diabetes with IBM’s strength in cognitive computing based on its Watson cognitive system. The companies will explore possibilities for improved diabetes care via insights from real-time, real world evidence of Novo Nordisk diabetes treatments and devices. By harnessing the potential of the Watson Health Cloud, Novo Nordisk aims to further advance its offerings to people living with diabetes and their healthcare professionals. “IBM is working with Novo Nordisk, a global leader in diabetes, to help the company create new e-health solutions on the Watson Health Cloud — accessing cognitive computing to help personalize care,” said Deborah DiSanzo, general manager of IBM Watson Health, in a statement. The International Diabetes Federation (IDF) estimates that 415 million people have diabetes today – a figure that IDF estimates could rise to 642 million by 2040. Complications from poorly managed diabetes include cardiovascular disease, kidney disease, nerve damage, and blindness. Diabetes and its complications account for 12 percent of global health expenditure or about $673 billion dollars annually.
“Working with ambitious partners like IBM Watson Health helps us explore the opportunities presented by an increasingly digitalized healthcare system,” said Riis, executive vice president of Novo Nordisk, in a statement. “We aim to leverage our combined capabilities to improve the lives of people with diabetes by making the management of the condition more simple, effective and measurable.”